AZD-2207
AZD-2207 is a cannabinoid receptor CB1 antagonist, known for its high lipophilicity. AZD-2207 has good intestinal permeability in the Caco-2 model and can be used in research related to type 2 diabetes and obesity[1].
Product Specifications
CAS Number
866598-45-0
UNSPSC
12352005
Target
Cannabinoid Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Metabolic Disease
Smiles
O=C(C1=C(C)N(C2=CC=C(C=C2)OS(=O)(CCC(F)(F)F)=O)C(C3=C(Cl)C=C(Cl)C=C3)=N1)NN4CCCCC4
Molecular Formula
C25H25Cl2F3N4O4S
Molecular Weight
605.46
References & Citations
[1]Christer Tannergren, et al. Biopharmaceutic Profiling of Salts to Improve Absorption of Poorly Soluble Basic Drugs. J Pharm Sci. 2016 Nov;105 (11) :3314-3323.|[2]Jin Hee Kim, et al. Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down-regulation of NF-kappaB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells. Biochem Pharmacol. 2006 Apr 14;71 (8) :1198-205.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
CB1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
252768-ML550 100 µL
TLR8 (Toll-like Receptor 8, CD288, MGC119599, MGC119600) (MaxLight 550)
Sign In for Pricing
View Details 
MBS6199654-01 0.1 mL
ATM (Serine-protein Kinase ATM, Ataxia Telangiectasia Mutated, A-T Mutated) (MaxLight 490)
Sign In for Pricing
View Details MBS6199654-02 5x 0.1 mL
ATM (Serine-protein Kinase ATM, Ataxia Telangiectasia Mutated, A-T Mutated) (MaxLight 490)
Sign In for Pricing
View Details GTR15177398 1 Vial
Lentiviral mouse Mnt shRNA (UAS) - Lentiviral mouse Mnt shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details MBS6341622-01 0.2 mL
RGL2, NT (RGL2, RAB2L, Ral guanine nucleotide dissociation stimulator-like 2, RalGDS-like factor, Ras-associated protein RAB2L) (Biotin)
Sign In for Pricing
View Details